LATEST ARTICLES

8th Plenary Meeting EHDN 2014 Barcelona: 19-21 settembre 2014 – Report

Annarita Bentivoglio* - Marina Frontali** Si è appena concluso l’ottavo meeting plenario del Network Europeo per la Malattia di Huntington. Oltre 900 partecipanti: l’incontro più numeroso...

Fatal cellular malfunction identified in Huntington’s disease

Researchers believe they have learned how mutations in the gene that causes Huntington’s disease kill brain cells, a finding that could open new opportunities...

New roles for huntingtin: removing a healthy protein to understand its...

This article was first published at en.hdbuzz.net Some techniques aimed at lowering mutant huntingtin can also affect the normal form of the protein. With clinical...

GLOBAL HUNTINGTON’S DISEASE PATIENT ADVOCACY ORGANIZATIONS UNITE TO FORM HUNTINGTON’S DISEASE...

This article was first published at www.hdsa.org The European Huntington Association (EHA), Huntington’s Disease Society of America (HDSA) and Huntington Society of Canada (HSC) are...

BioSensics™ Has Received over $2.5M in Grant Funding from the NIH...

BioSensics, a leader in developing wearable sensor technologies for clinical research and medical applications, has received grant funding from the National Institutes of Health...

George Yohrling, Ph.D Discusses Current and Potential HD Treatment Options

Since 2012, George Yohrling, PhD has served as the Senior Director, Mission and Scientific Affairs for the Huntington’s Disease Society of America (HDSA). In...

C-Path, CHDI, and CDISC Announce Public Review for Huntington’s Disease Therapeutic...

TUCSON, AZ, NEW YORK, NY, and AUSTIN, TX – September 11, 2017 – Critical Path Institute (C-Path), CHDI Foundation, Inc. (CHDI), and The Clinical Data Interchange Standards Consortium (CDISC) announce...